The contribution of rare genetic variants to the pathogenesis of polycystic ovary syndrome

Matthew Dapas, Andrea E Dunaif*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations

Abstract

Polycystic ovary syndrome (PCOS) is a highly heritable disorder, but only a small proportion of the heritability can be accounted for by common genetic risk variants identified to date. It is possible that variants with lower allele frequencies that cannot be detected using genome-wide association study arrays contribute to PCOS. Here, we discuss the challenges inherent to studying rare genetic variants in complex disease and review several recent studies that have used DNA sequencing techniques to investigate whether rare variants play a role in PCOS pathogenesis. We evaluate these findings in the context of the latest literature in PCOS and complex disease genetics.

Original languageEnglish (US)
Pages (from-to)26-32
Number of pages7
JournalCurrent Opinion in Endocrine and Metabolic Research
Volume12
DOIs
StatePublished - Jun 2020

Funding

This research was supported by the US National Institutes of Health grants P50HD044405 (A.D.) and R01 HD085227 (A.D.). M.D. was supported by the NRSA fellowship T32DK007169.

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Fingerprint

Dive into the research topics of 'The contribution of rare genetic variants to the pathogenesis of polycystic ovary syndrome'. Together they form a unique fingerprint.

Cite this